William Nicholson, MD
Interventional Cardiology · Atlanta, GANPI 1861435406
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.8%), ownership interests and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Corindus Inc. at 35.4% of the total. Reporting peaked in 2019 at $478,244 and has fallen 82.7% since, to $82,829 in 2025. Among interventional cardiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 666 payments — averaging $1501.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corindus Inc.$354K
- Boston Scientific$316K
- Shockwave Medical, Inc$102K
- Abbott$69K
- Medtronic$63K
- Teleflex LLC$35K
- plus $60K from 14 others
Across 203 payments — averaging $5053.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$235K
- Philips North America LLC$208K
- Boston Scientific$205K
- Shockwave Medical, Inc$204K
- Arrow International, Inc.$111K
- Corindus Inc.$39K
- plus $24K from 4 others
What the payments were for
- Consulting fees$133,62513%
- Speaking & faculty fees$437,94144%
- Travel & lodging$51,7875%
- Food & beverage$23,3492%
- Education$20%
- Entertainment$840%
- Ownership interest$352,99035%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corindus Inc. | 8 | $353,965 |
| Boston Scientific | 260 | $316,441 |
| Shockwave Medical, Inc | 55 | $102,009 |
| Abbott | 57 | $68,766 |
| Medtronic(2 entities) | 177 | $63,223 |
| Teleflex LLC | 18 | $35,268 |
| Abiomed | 23 | $17,746 |
| Arrow International, Inc. | 12 | $14,689 |
| Asahi Intecc USA, Inc. | 17 | $14,325 |
| Cordis US CORP. | 1 | $8,800 |
| Edwards Lifesciences | 11 | $1,723 |
| Siemens Medical Solutions USA, Inc. | 8 | $1,340 |
| Avinger Inc. | 2 | $764 |
| Heartflow, Inc. | 3 | $173 |
| Cardiovascular Systems Inc. | 7 | $139 |
| Baylis Medical Company Inc | 2 | $109 |
| W. L. Gore & Associates, Inc. | 2 | $105 |
| Seigla Medical, Inc. | 1 | $91 |
| Verge Medical, Inc. | 1 | $88 |
| Cardinal Health 200 LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL VASCULAR ACCESS$150,390
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$76,838
- CROSSBOSS$66,113
- Xience V coronary stent system$29,473
- Vascular Lithotripsy$24,750
- GUIDELINER$22,429
- Dragonfly OCT$20,523
- TURNPIKE$18,756
- Resolute$18,625
- RESOLUTE ONYX$17,915
- Impella$17,373
- DRAGONFLY OPSTAR$14,486
- SYMPLICITY G3$9,079
- ASAHI PTCA Guide Wire$7,753
- MANTA$7,352
- STINGRAY$6,276
- Asahi Peripheral Vascular Wires$6,000
- GENERAL - THERAPIES$4,734
- HI-TORQUE BALANCE$2,299
- GENERAL VASCULAR INTERVENTION$2,250
How this compares
$999,778 in reported general payments places this provider in the 95th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $35,824 |
| BrilintaTicagrelor | 20 | $19,995 |
| Prasugrel Hcl | 13 | $2,007 |
| Atorvastatin Calcium | 68 | $882 |
| Ranolazine ErRanolazine | 21 | $846 |
| ClopidogrelClopidogrel Bisulfate | 82 | $815 |
| Metoprolol Succinate | 31 | $450 |
| Losartan Potassium | 34 | $361 |
| Ezetimibe | 19 | $352 |
| Carvedilol | 26 | $262 |
| Rosuvastatin Calcium | 18 | $151 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 19 | $149 |
| Amlodipine Besylate | 26 | $81 |
| Lisinopril | 20 | $55 |
| Furosemide | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Atlanta
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Adam GreenbaumAtlanta$238K
- Wissam JaberAtlanta$222K
- Katherine KunkelAtlanta$189K
- James StewartAtlanta$174K
- Pratik SandesaraAtlanta$165K
- Chandanreddy DevireddyAtlanta$121K
- Prashant KaulAtlanta$109K
- Nikoloz ShekiladzeAtlanta$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.